|
|
Article: Helix BioPharma Corp. Announces Fiscal 2009 Results.(Financial report)
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Helix BioPharma Corp. (TSX, FSE: HBP / OTCQX: HXBPF) announced financial results for the year ended July 31, 2009 (see also Biopharmaceuticals).
During the 2009 fiscal year, the Company continued to make progress with its development initiatives for its lead drug candidates, L-DOS47 and Topical Interferon Alpha-2b. The following are selected highlights during the 2009 fiscal year and subsequent to year-end.
...